China & India: Behind Returns
30 Aug 2024
US$ 99.00
Declining distribution from China’s PE-backed assets underscores risks of sole reliance on one major exit route for c...
Related Publications
YuanBio Venture Capital has led the near Rmb800 m (US$119.2 m) series D funding round of Beijing Inno Medicine ......
Accel, Multiply Ventures have led a US$4 m pre-series A funding round of Fundly.ai, a fintech and B2B commerce platform...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.